PeptiDream Inc.

Tokyo Stock Exchange 4587.T

PeptiDream Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD 1.87 M

PeptiDream Inc. Net Cash Used Provided By Financing Activities is USD 1.87 M for the year ending December 31, 2023, a -98.82% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • PeptiDream Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 158.50 M, a 27,519.86% change year over year.
  • PeptiDream Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD 573.86 K, a 125.00% change year over year.
  • PeptiDream Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD -2.30 M, a -975.35% change year over year.
  • PeptiDream Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 262.27 K, a -0.71% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4587.T

PeptiDream Inc.

CEO Dr. Patrick Crawford Reid Ph.D.
IPO Date June 12, 2013
Location Japan
Headquarters 3-25-23 Tonomachi
Employees 745
Sector Healthcare
Industries
Description

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.

Similar companies

4974.T

Takara Bio Inc.

USD 6.72

0.74%

4507.T

Shionogi & Co., Ltd.

USD 14.33

-1.63%

2413.T

M3, Inc.

USD 9.09

-1.21%

2127.T

Nihon M&A Center Holdings Inc.

USD 3.91

0.25%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 45.71

2.52%

StockViz Staff

February 8, 2025

Any question? Send us an email